UNSPSC 51386401: Balsalazide

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P80AL8J7ZP. European Medicines Agency schedules Balsalazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06092MIG. Balsalazide generally arises in the molecular formula C17H15N3O6.

UNSPSC 51386401 Balsalazide, a Commodity code, nominally names a specific pharmaceutical active ingredient, but the single recent state and local opportunity tagged under it does not reflect that scope. Seminole County, Florida posted an IFB in June 2026 for procurement of naloxone and safe drug deactivation systems — a public-health harm-reduction purchase unrelated to balsalazide, which is an anti-inflammatory bowel disease medication. The mismatch suggests either a classification error in the county's internal tagging or that this code has drifted in practice to encompass a broader pharmaceutical and medical-supply category than the code name suggests. Based on available records, the code shows minimal recent activity in state and local procurement and does not reflect a robust or active solicitation pattern.

The single opportunity on file is Seminole County's IFB60459723LAS, due July 26, 2023, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with one-year renewal option, fixed-fee pricing, and standard compliance requirements including E-Verify, drug-free workplace certification, and workers' compensation insurance. Bidders must include all shipping and delivery costs in their proposals. The procurement does not name explicit set-aside designations, though potential FEMA funding introduces federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act. Business development professionals should treat this code as inactive for state and local opportunity pursuit pending evidence of broader or more frequent solicitation activity.